Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Entrada Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 116 | 4 | 113 | +1 |
| Shares | 28.5M | 4.54M | 24.4M | +496.1K (+2.1%) |
| Value | $164.8M | $26.4M | $251.0M | +$112.5M (+81.3%) |
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Entrada Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 142,110 | $1.46M | 0.01% |
| Sphera Funds Management Ltd. | 110,942 | $1.14M | 0.24% |
| Lynx1 Capital Management LP | 51,689 | $531.4K | 0.11% |
| Brevan Howard Capital Management LP | 47,967 | $493.1K | 0.01% |
| ExodusPoint Capital Management, LP | 37,430 | $384.8K | 0.00% |
| Canada Pension Plan Investment Board | 25,600 | $263.2K | 0.00% |
| Dynamic Technology Lab Private Ltd | 25,302 | $260.0K | 0.06% |
| Creative Planning | 22,082 | $227.0K | 0.00% |
| Point72 Asset Management, L.P. | 21,871 | $224.8K | 0.00% |
| Marshall Wace, LLP | 20,657 | $212.4K | 0.00% |
| Balyasny Asset Management LLC | 14,017 | $144.1K | 0.00% |
| Magnetar Financial LLC | 13,373 | $137.5K | 0.00% |
| Massmutual Trust Co FSB | 186 | $1.91K | 0.00% |
| Signaturefd, LLC | 167 | $1.72K | 0.00% |
| Cornerstone Financial Management LLC | 91 | $935 | 0.00% |
| Rothschild Investment LLC | 2 | $21 | 0.00% |
Sold out (15)
Institutions that held Entrada Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Gsa Capital Partners LLP | 55,960 | $325.0K |
| Two Sigma Advisers, LP | 51,500 | $298.7K |
| Atom Investors LP | 30,812 | $178.7K |
| Occudo Quantitative Strategies LP | 29,486 | $171.0K |
| Oxford Asset Management LLP | 29,161 | $169.1K |
| Prelude Capital Management, LLC | 25,754 | $149.4K |
| Sherbrooke Park Advisers LLC | 18,573 | $107.7K |
| Virtus Investment Advisers, Inc. | 14,495 | $84.1K |
| GWM Advisors LLC | 14,167 | $82.2K |
| Jain Global LLC | 11,954 | $69.3K |
| STRS Ohio | 3,800 | $22.0K |
| Federated Hermes, Inc. | 2,018 | $11.7K |
| Global Retirement Partners, LLC | 250 | $1.45K |
| Clearstead Advisors, LLC | 115 | $667 |
| IFP Advisors, Inc | 2 | $12 |
Not filed for Q4 2025 yet (4)
Institutions that held Entrada Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| MPM Asset Management LLC | 4,381,062 | $25.4M |
| Cubist Systematic Strategies, LLC | 122,676 | $711.5K |
| Corton Capital Inc. | 38,849 | $225.3K |
| Point72 (DIFC) Ltd | 1,358 | $7.88K |